Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Loading Events

« All Events

OBN C-Suite Breakfast: ‘Spring Spending Review’

May 7 @ 8:30 am

OBN’s May C-Suite Breakfast, hosted by FTI Consulting in London, will bring together senior leaders from across the life sciences sector for a high-level round-table discussion. The event will feature keynote insights on the Spring Spending Review, followed by case studies and interactive debate.

Designed exclusively for C-Suite executives and senior decision-makers, these discussions aim to push boundaries, generate valuable industry insights, and create practical thought-leadership output. Attendees will have the opportunity to exchange ideas, tackle key challenges, and explore opportunities shaping the sector.

Go to Top